Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Multiple Dose Study Of PF-05161704 In Healthy Volunteers

Phase 1

Terminated

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: PF-05161704 or Placebo

First Posted Date: 2010-09-15

Last Posted Date: 2011-03-11

Lead Sponsor: Pfizer

Target Recruit Count: 32

Registration Number: NCT01202266

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Phase 2

Completed

Conditions: Diabetic Nephropathies

Interventions: Drug: Placebo
Drug: PF-00489791

First Posted Date: 2010-09-13

Last Posted Date: 2019-03-12

Lead Sponsor: Pfizer

Target Recruit Count: 256

Registration Number: NCT01200394

Locations: 🇺🇸
North America Research Institute, Azusa, California, United States
🇺🇸
California Kidney Specialists, San Dimas, California, United States
🇺🇸
Research Across America, Houston, Texas, United States

and more 153 locations

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Terminated

Conditions: Hypertension

Interventions: Drug: Amlodipine + Olmesartan medoxomil

First Posted Date: 2010-09-13

Last Posted Date: 2021-08-17

Lead Sponsor: Pfizer

Target Recruit Count: 615

Registration Number: NCT01200407

Locations: 🇵🇭
Private Clinic, Tuguegarao City, Philippines
🇵🇭
Metropolitan Medical Center Institutional Review Board, Manila, Philippines
🇵🇭
Pines City Doctors Hospital, Baguio, Philippines

and more 13 locations

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Phase 3

Completed

Conditions: Healthy Subjects

Interventions: Biological: 13-valent pneumococcal conjugate vaccine (13vPnC)
Biological: 7-valent pneumococcal conjugate vaccine (7vPnC)
Biological: diphtheria, tetanus, and acellular pertussis vaccine (DTaP)
Biological: DTaP

First Posted Date: 2010-09-13

Last Posted Date: 2018-12-19

Lead Sponsor: Pfizer

Target Recruit Count: 551

Registration Number: NCT01200368

Locations: 🇯🇵
National Hospital Organization Kure Medical Center, Kure, Hiroshima, Japan
🇯🇵
Harada Clinic, Fukuoka, Japan
🇯🇵
Childrens Clinic of Kose, Kofu, Yamanashi, Japan

and more 29 locations

Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-04171327
Drug: Prednisone

First Posted Date: 2010-09-13

Last Posted Date: 2010-12-17

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT01199900

Locations: 🇺🇸
Pfizer Investigational Site, Kalamazoo, Michigan, United States

Effect of Prevnar 13 on Ear Infections in Children

Completed

Conditions: Otitis Media

Interventions: Procedure: Tympanocentesis
Procedure: Nose/throat swab
Biological: Observational

First Posted Date: 2010-09-10

Last Posted Date: 2017-03-01

Lead Sponsor: Pfizer

Target Recruit Count: 239

Registration Number: NCT01199016

Locations: 🇺🇸
Penfield Pediatrics, Penfield, New York, United States
🇺🇸
Long Pond Pediatrics, Rochester, New York, United States
🇺🇸
Pathway Pediatrics, Rochester, New York, United States

and more 4 locations

Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-04308515
Drug: Prednisone

First Posted Date: 2010-09-10

Last Posted Date: 2010-12-16

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT01199029

Locations: 🇺🇸
Pfizer Investigational Site, Kalamazoo, Michigan, United States

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

Phase 1

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: AAB-003 (PF-05236812)
Other: Placebo

First Posted Date: 2010-09-02

Last Posted Date: 2017-02-23

Lead Sponsor: Pfizer

Target Recruit Count: 88

Registration Number: NCT01193608

Locations: 🇺🇸
Atlanta Center for Medical Research, Atlanta, Georgia, United States
🇺🇸
Belmont Center for Comprehensive Treatment, Philadelphia, Pennsylvania, United States
🇺🇸
Foers Medical Arts Pharmacy, Bethesda, Maryland, United States

and more 26 locations

A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

Phase 4

Completed

Conditions: Pneumococcal Infections

Interventions: Biological: Prevenar

First Posted Date: 2010-09-02

Last Posted Date: 2013-11-20

Lead Sponsor: Pfizer

Target Recruit Count: 505

Registration Number: NCT01193582

Locations: 🇨🇳
Baolixiang Clinic, Baoli Town,Yongfu County, Guangxi, China
🇨🇳
Luojin Clinic, Luojin Town, Yongfu County, Guangxi, China
🇨🇳
Guangfuxiang Clinic, Guangfu Town, Yongfu County, Guangxi, China

and more 2 locations

Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-04995274

First Posted Date: 2010-09-01

Last Posted Date: 2018-12-03

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT01193062

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy